SPAMLO-3.0 : Having Fun Shedding Light on Darkness, a Playful Approach to Reduce Anxiety in Palliative Care
SPAMLO 3 0
2 other identifiers
interventional
280
1 country
1
Brief Summary
End-of-life care is often accompanied by anxiety-not only for patients in palliative care, but also for their loved ones and the healthcare professionals supporting them. This anxiety may stem from a fear of death, loss of functional abilities, or a worsening of symptoms as the illness progresses. It contributes to emotional, psychological, and physical suffering, ultimately diminishing patients' quality of life. Most data on palliative care focus on cancer patients, among whom anxiety prevalence varies greatly, but may affect more than 70% of individuals. Currently, anxiety in palliative care patients is managed through non-pharmacological approaches (such as environmental modifications and relaxation techniques) and/or pharmacological treatments (including antidepressants, neuroleptics, and anxiolytics). The investigators recently developed the serious game SPAMLO with the aim to present and raise awareness about palliative care. The educational scenario was built around three settings: the hospital, the home, and the nursing home (EHPAD). The participant will follow Vito, a virtual character, whose sister is receiving palliative care. Vito will explore the different types of support available, starting at the hospital. He will learn about what a collegial discussion is, the Clayes-Léonetti law, advance directives, the trusted person, as well as the specificities of pediatrics. Through home hospitalization, Vito will discover palliative care outside the hospital setting, including home adaptations with appropriate equipment and the various available support services. Finally, Vito will visit the nursing home, where topics such as oral care, respecting the patient's choices, and the importance of preserving them will be addressed. Thanks to its playful approach and the knowledge gained, this game could help reduce anxiety in palliative care patients through non-pharmacological means. This research project has beeen co-designed with a JALMALV volunteer (Accompany life until death - french association).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 30, 2025
CompletedStudy Start
First participant enrolled
July 1, 2025
CompletedFirst Posted
Study publicly available on registry
July 17, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
April 1, 2027
July 17, 2025
July 1, 2025
1.8 years
June 30, 2025
July 9, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Hospital Anxiety and Depresion Scale
Questionnaire completed by the participant. It consists of 14 items rated from 0 to 3. Seven questions relate to anxiety (total A) and the other seven to the depressive dimension (total D), thus allowing for the calculation of two scores (maximum score for each = 21). The scores for each of the Anxiety and Depression subscales are interpreted as follows: 0 to 7: no signs of anxiety and/or depressive disorders. 8 to 10: borderline or doubtful symptomatology. 11 to 21: confirmed anxiety and/or depressive disorders of varying severity.
Day 0, Day 15 and Day 30
Secondary Outcomes (7)
Acceptability of the serious game through a Likert questionnaire
Day 30
Number of participants who completed the serious game.
Through study completion, an average of 20 months
French System Usability Scale
Through study completion, an average of 20 months
McGill Quality of Life Questionnaire
Day 0, Day 15 and Day 30
Insomnia Severity Index
Day 0 and Day 30
- +2 more secondary outcomes
Study Arms (2)
Intervention group
EXPERIMENTALStandard care by the healthcare team and participation in the serious game "SPAMLO-3.0."
Control group
NO INTERVENTIONStandard care provided by the mobile palliative care team, according to the usual practices of the healthcare team.
Interventions
Eligibility Criteria
You may qualify if:
- Participant for whom no curative treatment is proposed, who is either discharged home or hospitalized in palliative care
- Life expectancy presumed to be greater than one month
- No cognitive impairments, according to the healthcare team's assessment
- Participantt has given free and informed consent
- Participant affiliated with a social security system
- The participant owns a computer, tablet, or smartphone with an internet connection and agrees to participate in the serious game SPAMLO-3.0.
You may not qualify if:
- Participant who is demented, confused, or in a coma
- Fatigability, according to the healthcare team's assessment
- Visually or hearing impaired participant, according to the healthcare team's assessment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre Hospitalier de Saint-Brieuc - Paimpol - Tréguier
Saint-Brieuc, 22000, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Stéphanie LOUICHE
Centre Hospitalier de Saint-Brieuc - Paimpol - Tréguier
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 30, 2025
First Posted
July 17, 2025
Study Start
July 1, 2025
Primary Completion (Estimated)
April 1, 2027
Study Completion (Estimated)
April 1, 2027
Last Updated
July 17, 2025
Record last verified: 2025-07